Emergent CEO: J&J vaccine production could resume in days
Emergent CEO: J&J vaccine production could resume in days Nathaniel Weixel © Getty Emergent CEO: J&J vaccine production could resume in days Emergent BioSolutions could resume manufacturing doses of Johnson & Johnson's coronavirus vaccine "within a matter of days," the company's CEO Robert Kramer told a House panel Wednesday. Democratic lawmakers on the House Coronavirus Crisis Subcommittee pressed Kramer on Emergent's ability to fix a host of manufacturing issues identified by a Food and Drug Administration (FDA) inspection of its Baltimore facility in April. At least one ...
Source: msn.com